Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer BTI BAT flags smokeless product segment momentum as top growth driver in latest quarterly results NGS Natural shares gain 331 percent despite posting a 151 percent negative EPS surprise for Q4 2025